pyrifos通过抑制永生GnRH神经元中的mTOR途径来诱导自
Gabriele Lori1, Lucia Coppola1, Marialuisa Casella2
1Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.
Chemosphere
|June 30, 2024
概括
pyrifos (CPF) 农药暴露抑制了mTOR信号传递,并诱导了小鼠GNRH神经元的自,即使在人类相关的低度下,也会影响下丘脑-垂体-腺 (HPG) 轴.
科学领域:
- 神经内分泌学神经内分泌学
- 毒理学 毒理学 毒理学
- 细胞生物学 细胞生物学
背景情况:
- pyrifos (CPF) 是一种广泛使用的农药,与神经发育和生殖问题有关.
- 造成CPF影响的机制,特别是在下丘脑,仍然不清楚.
- 脑下垂体 - 脑下垂体 - 卵巢 (HPG) 轴对于生殖功能至关重要,并且可以因环境因素而受到干扰.
研究的目的:
- 在人体相关度 (1 nM-100 nM) 下,研究 CPF 作用的分子机制在小鼠下丘脑的 GnRH 神经元 (GT1-7) 中.
- 评估CPF对神经元活力,增殖,亡和功能的影响.
- 阐明CPF对基因和蛋白质表达的影响,特别是与HPG轴相关的影响.
主要方法:
- 进行了细胞活力,增殖和亡测试.
- 使用了基因表达,传输电子显微镜 (TEM) 和蛋白质组学.
- 免疫光学和西部涂抹 (WB) 验证了关键发现.
主要成果:
- 在100nM时,CPF降低了细胞活力和GnRH分泌/基因表达.
- CPF诱导了雌激素受体α/β,雄激素受体,芳酶和催产素受体的基因表达.
- CPF抑制了mTOR信号传递,导致自和线粒体损伤,由TEM和WB证实.
结论:
- CPF作为一个mTOR路径抑制剂,诱导GnRH神经元的自.
- 建议在CPF的作用中可能涉及雌激素受体α/雄激素受体信号传递.
- 在纳米度下,CPF对下丘脑的不良影响引发了对HPG轴中断的担忧.
更多相关视频
10:50Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
997
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
8.6K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
